This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): GSK2321138A, quadrivalent influenza vaccine, FLU D-QIV, Influsplit Tetra (Germany), Fluarix Tetra (UK)
Fluarix Quadrivalent is a quadrivalent inactivated influenza vaccine (QIV). It contains split virions from 2 type A and two type B influenza strains that are chosen each year by the USPHS based on which influenza strains are expected to be most prevalent.
Fluarix quadrivalent is produced in influenza-infected chicken eggs and contains no adjuvant.
Fluarix Quadrivalent News
Additional information available to subscribers only: